Prostate cancer and breast cancer can be visualized and treated with targeted radioactive molecules. Prior treatment e.g. anti-hormonal treatment or chemotherapeutics can influence the success hereof. In this project the influence of prior treatment will be studied to determine when and in whom radioactive molecules can best be applied.
Ultimately the results of this project will lead to improved patient selection, thereby increasing the success of GRPR-mediated radionuclide imaging and/or treatment and preventing unnecessary interventions.